GlassScriptPhysician profile
Kevin Robert Monaghan
NPI 1013223262
$5,198.16
in general payments reported to CMS, 2019-2025
15 companies · $2,328 in 2025
The $2,328 reported for 2025 was more than what 97% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,475 · 2022: $1,284 · 2024: $111 · 2025: $2,328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,768 · Food and Beverage: $671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,767.85 |
| Food and Beverage | $670.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Peerless Surgical INC. | $3,130.18 | 2021-2025 | |
| Arthrex, INC. | $1,702.26 | 2022-2025 | |
| Treace Medical Concepts, INC. | $48.26 | 2024 | |
| Orthalign INC | $44.51 | 2021 | |
| Vericel Corporation | $43.54 | 2021-2024 | Maci |
| Medela LLC | $37.47 | 2021 | |
| Medtronic, INC. | $35.36 | 2021-2024 | Kyphon Express II Kyphopak Tray |
| Solventum Corporation | $25.35 | 2025 | Activ.A.C., V.A.C. Veraflo, Prevena |
| Zimmer Biomet Holdings, INC. | $24.86 | 2021 | |
| Conformis, INC. | $24.71 | 2021 | |
| Hydrofera LLC | $20.95 | 2024 | Hydrofera Blue |
| Ferring Pharmaceuticals INC. | $16.98 | 2021 | |
| Heron Therapeutics, INC. | $16.81 | 2022 | |
| Curonix LLC | $14.51 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pacira Therapeutics, INC. | $12.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Monaghan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.